English  |  正體中文  |  简体中文  |  總筆數 :2854037  
造訪人次 :  45345442    線上人數 :  1666
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

跳至: [ 中文 ] [ 數字0-9 ] [ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z ]
請輸入前幾個字:   

顯示項目 335721-335730 / 2346788 (共234679頁)
<< < 33568 33569 33570 33571 33572 33573 33574 33575 33576 33577 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
臺大學術典藏 2019-08-30T03:50:09Z Disease-inducible transgene expression from a recombinant adeno- associated virus vector in a rat arthritis model Pan R.Y.;Xiao X.;Show-Li Chen;Li J.;Lin L.-C.;Wang H.-J.;Tsao Y.-P.; Pan R.Y.; Xiao X.; SHOW-LI CHEN; Li J.; Lin L.-C.; Wang H.-J.; Tsao Y.-P.
臺北醫學大學 2008 Disease-Modifying Effects of Glucosamine HCL Involving Regulation of Metallopproteinases and Chemokines.Activated by Interleukin-ib in Human Primary Synovial Fibroblasts 謝銘勳; Lu; H.T.Lian; Y.C.; Sheu; M.T.; Ho; H.O.; Lin; Y.T.; Hsieh; M.S.; Chen; C.H.
臺北醫學大學 2008 Disease-modifying effects of glucosamine HCl involving regulation of metalloproteinases and chemokines activated by interleukin-1β in human primary synovial fibroblasts. 梁有志; 陳建和; Lu HT#; Liang YC#; Sheu MT; Ho HO; Lin YT; Hsieh MS; Chen CH
臺北醫學大學 2007 Disease-modifying effects of glucosamine HCl involving regulation of metalloproteinases and chemokinesactivated by interleukin-1B in human primary synovial fibroblasts 何秀娥; Lu HT; Liang YC; Sheu MT; Ho HO; Lin YT; Hsieh MS; Chen CH
臺北醫學大學 2010-02 Disease-modifying Effects of Glucosamine on Interleukin-1b-treated Chondrosarcoma Cells (SW1353) Under Normoxic and Hypoxic Conditions Ta-Liang Chen; Ming-Thau Sheu; Yu-Chih Liang; Yu-Ju Lin; Ming-Shium Hsieh; Chien-Ho Chen
臺北醫學大學 2010 Disease-modifying effects of glucosamine on interleukin-1β-treated chondrosarcoma cells under normocic and hypoxic conditions TL, Chen;MT, Sheu;YC, Ling;YJ, Lin;MS, Hsieh;CH, Chen
臺大學術典藏 2021-08-20T08:20:02Z Disease-modifying medications in heart failure: More than ACE inhibitors and beta blockers CHIA-TER CHAO
國家衛生研究院 2023-10-05 Disease-modifying therapies and features linked to treatment response in type 1 diabetes prevention: A systematic review Felton, JL; Griffin, KJ; Oram, RA; Speake, C; Long, SA; Onengut-Gumuscu, S; Rich, SS; Monaco, GSF; Evans-Molina, C; DiMeglio, LA; Ismail, HM; Steck, AK; Dabelea, D; Johnson, RK; Urazbayeva, M; Gitelman, S; Wentworth, JM; Redondo, MJ; Sims, EK; Tobias, DK; Merino, J; Ahmad, A; Aiken, C; Benham, JL; Bodhini, D; Clark, AL; Colclough, K; Corcoy, R; Cromer, SJ; Duan, D; Felton, JL; Francis, EC; Gillard, P; Gingras, V; Gaillard, R; Haider, E; Hughes, A; Ikle, JM; Jacobsen, LM; Kahkoska, AR; Kettunen, JLT; Kreienkamp, RJ; Lim, L-L; Männistö, JME; Massey, R; McLennan, N-M; Miller, RG; Morieri, ML; Most, J; Naylor, RN; Ozkan, B; Patel, KA; Pilla, SJ; Prystupa, K; Raghavan, S; Rooney, MR; Schön, M; Semnani-Azad, Z; Sevilla-Gonzalez, M; Svalastoga, P; Takele, WW; Tam, CH-t; Thuesen, ACB; Tosur, M; Wallace, AS; Wang, CC; Wong, JJ; Yamamoto, JM; Young, K; Amouyal, C; Andersen, MK; Bonham, MP; Chen, M; Cheng, F; Chikowore, T; Chivers, SC; Clemmensen, C; Dabelea, D; Dawed, AY; Deutsch, AJ; Dickens, LT; DiMeglio, LA; Dudenhöffer-Pfeifer, M; Evans-Molina, C; Fernández-Balsells, MM; Fitipaldi, H; Fitzpatrick, SL; Gitelman, SE; Goodarzi, MO; Grieger, JA; Guasch-Ferré, M; Habibi, N; Hansen, T; Huang, C; Harris-Kawano, A; Ismail, HM; Hoag, B; Jones, AG; Koivula, RW; Leong, A; Leung, GKW; Libman, IM; Liu, K; Lowe, WL; Morton, RW; Motala, AA; Onengut-Gumuscu, S; Pankow, JS; Pathirana, M; Pazmino, S; Perez, D; Petrie, JR; Powe, CE; Quinteros, A; Jain, R; Ray, D; Ried-Larsen, M; Saeed, Z; Santhakumar, V; Kanbour, S; Sarkar, S; Monaco, GSF; Scholtens, DM; Selvin, E; Sheu, WH-H; Stanislawski, MA; Steenackers, N; Steck, AK; Stefan, N; Støy, J; Taylor, R; Tye, SC; Ukke, GG; Urazbayeva, M; Van der Schueren, B; Vatier, C; Wentworth, JM; Hannah, W; White, SL; Yu, G; Zhang, Y; Zhou, SJ; Beltrand, J; Polak, M; Aukrust, I; de Franco, E; Flanagan, SE; Maloney, KA; McGovern, A; Molnes, J; Nakabuye, M; Njølstad, PR; Pomares-Millan, H; Provenzano, M; Saint-Martin, C; Zhang, C; Zhu, Y; Auh, S; de Souza, R; Fawcett, AJ; Gruber, C; Mekonnen, EG; Mixter, E; Sherifali, D; Eckel, RH; Nolan, JJ; Philipson, LH; Brown, RJ; Billings, LK; Boyle, K; Costacou, T; Dennis, JM; Florez, JC; Gloyn, AL; Gomez, MF; Gottlieb, PA; Greeley, SAW; Griffin, K; Hattersley, AT; Hirsch, IB; Hivert, M-F; Hood, KK; Josefson, JL; Kwak, SH; Laffel, LM; Lim, SS; Loos, RJF; Ma, RCW; Mathieu, C; Mathioudakis, N; Meigs, JB; Misra, S; Mohan, V; Murphy, R; Oram, R; Owen, KR; Ozanne, SE; Pearson, ER; Perng, W; Pollin, TI; Pop-Busui, R; Pratley, RE; Redman, LM; Reynolds, RM; Semple, RK; Sherr, JL; Sims, EK; Sweeting, A; Tuomi, T; Udler, MS; Vesco, KK; Vilsbøll, T; Wagner, R; Rich, SS; Franks, PW; Ada/Easd, P
國立成功大學 2021-03-23 Disease-related disability burden: a comparison of seven chronic conditions in middle-aged and older adults Chou;Chieh-Ying;Chiu;Ching-Ju;Chang;Chia-Ming;Wu;Chih-Hsing;Lu;Feng-Hwa;Wu;Jin-Shang;Yang;Yi-Ching
國家衛生研究院 2013-07-18 Disease-related growth factor and embryonic signaling pathways modulate an enhancer of TCF21 expression at the 6q23.2 coronary heart disease locus Miller, CL;Anderson, DR;Kundu, RK;Raiesdana, A;Nürnberg, ST;Diaz, R;Cheng, K;Leeper, NJ;Chen, CH;Chang, IS;Schadt, EE;Hsiung, CA;Assimes, TL;Quertermous, T

顯示項目 335721-335730 / 2346788 (共234679頁)
<< < 33568 33569 33570 33571 33572 33573 33574 33575 33576 33577 > >>
每頁顯示[10|25|50]項目